Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
about
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaCombinatorial peptide libraries: mining for cell-binding peptides.TAT-LHRH conjugated low molecular weight chitosan as a gene carrier specific for hepatocellular carcinoma cellsImaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) geneSodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Generation of a tumor- and tissue-specific episomal non-viral vector system.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Targeted polymeric nanoparticles for cancer gene therapy.Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cellsSystemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery.PolyIC GE11 polyplex inhibits EGFR-overexpressing tumorsDrug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting.Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.Gene therapy and imaging in preclinical and clinical oncology: recent developments in therapy and theranostics.Molecular Imaging in Nanotechnology and Theranostics.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery.De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells.Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS GeneReceptor Crosslinking in Drug Delivery: Detour to the Lysosome?Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice.Solid-phase supported design of carriers for therapeutic nucleic acid delivery.EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.Biodistribution of TAT-LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts.EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.Target-specific delivery of siRNA into hepatoma cells' cytoplasm by bifunctional carrier peptide.Anti-metastatic effect of 131I-labeled Buthus martensii Karsch chlorotoxin in gliomas
P2860
Q28068437-8E6295E6-9FC7-4160-93FD-F28441A5620CQ31144876-D5BB5BF3-2A97-4891-AFA4-C3976299FA59Q33769475-AED66B0C-E4C9-4B3B-8DAF-FC3683AF75FAQ33779491-9E2DEF8E-3913-4E1D-AD43-D87A4A379ED7Q34303955-B95C4DC1-110D-4C33-90B1-CF8FA24A74DCQ34756391-7F4B4384-8037-4AC7-83B2-C42DAF7CE69DQ34762840-3252F8B8-23D1-405C-8579-6D11353AAD9AQ35612571-9463533C-59E1-4282-941E-CE6FE2DAE1BAQ36416427-2BAFC18F-DA94-4CE8-9949-09647B73D0C6Q36512528-8F3FB2AE-F12A-407B-936C-A87231A8633DQ36673686-23377071-F3A8-40C3-AB42-659853E27F7FQ36793350-AA50934C-C929-4FCD-8ECB-A4653CEC6D2DQ37014230-769383E7-B3CC-422D-B5A5-7BE4D9813950Q37639772-1134FC83-6FD1-4778-A535-2A3F02CCEEAAQ38271422-2F7A3D8A-C3E9-4886-8EF4-9F3D764AFB7FQ38297124-FAE997B0-7ADF-4AE7-A14D-C51D0211A5A2Q38738754-8A196BBB-A7ED-468F-87EE-61810E7CE0EDQ38772380-7C5656EE-E058-4EEE-A937-945B46E349F6Q38852900-C27FF8E5-93B2-4476-A057-3FD2BD4C3B5DQ39134517-F5EFC77D-2E1E-4573-A9BC-451D2C95EFFDQ39530004-A2D264F4-C6D9-4E6B-BF0E-3D2334CB220BQ41866984-93BBDD09-FA31-42B9-A9B1-ADF18C667E8CQ42069859-73E5668D-6C29-4F74-8C12-EFE964909B7EQ42127600-E5E069C9-87F8-4421-B2CD-9E84193FE03DQ42921833-36D8AD09-8130-4FFA-A2F5-4C0614ADC091Q45326571-37C30FE0-9C7C-43AF-A246-2CDA2B806FC8Q45866837-ECB54F8B-D1CE-4C66-9A1E-CF699773A7A4Q45885714-F2014285-3BBB-4B8F-916A-7132D6FFC65FQ48119581-C75D7F19-F574-4087-8907-595342F45EE8Q51091545-D101C521-EBBF-45AD-8D3C-B8702DC9235FQ57056127-F1C0CD54-A6EF-4C51-9DD2-5320D5C557A7
P2860
Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epidermal growth factor recept ...... sodium iodide symporter gene.
@ast
Epidermal growth factor recept ...... sodium iodide symporter gene.
@en
Epidermal growth factor receptor-targeted
@nl
type
label
Epidermal growth factor recept ...... sodium iodide symporter gene.
@ast
Epidermal growth factor recept ...... sodium iodide symporter gene.
@en
Epidermal growth factor receptor-targeted
@nl
prefLabel
Epidermal growth factor recept ...... sodium iodide symporter gene.
@ast
Epidermal growth factor recept ...... sodium iodide symporter gene.
@en
Epidermal growth factor receptor-targeted
@nl
P2093
P2860
P356
P1433
P1476
Epidermal growth factor recept ...... sodium iodide symporter gene.
@en
P2093
Burkhard Göke
Christian Zach
Christine Spitzweg
David Schaffert
Franz J Gildehaus
Geoffrey K Grünwald
Kathrin Klutz
Manfred Ogris
Michael J Willhauck
Nathalie Wunderlich
P2860
P304
P356
10.1038/MT.2010.296
P50
P577
2011-01-18T00:00:00Z